RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Starpharma Holdings - Stock

Starpharma Holdings Dividend 2024

Starpharma Holdings Dividend

0 AUD

Starpharma Holdings Dividend yield

Ticker

SPL.AX

ISIN

AU000000SPL0

WKN

796461

How much dividend does Starpharma Holdings 2024 pay?

According to the latest status from June 2024, Starpharma Holdings paid a total of 0 AUD per share in dividends within the last 12 months. With the current Starpharma Holdings price of 0.09 AUD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Starpharma Holdings Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Starpharma Holdings Dividend Safe?

Starpharma Holdings has been increasing the dividend for 0 years.

Over the past 10 years, Starpharma Holdings has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Starpharma Holdings's Dividend Distributions

Starpharma Holdings’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Starpharma Holdings's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Starpharma Holdings's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Starpharma Holdings’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Starpharma Holdings Aktienanalyse

What does Starpharma Holdings do?

Starpharma Holdings Ltd is an Australian company specializing in the development of innovative solutions in the fields of pharmacy and biotechnology. The company was founded in 1996 and has since written an impressive history full of successful developments and numerous partnerships. The main business of Starpharma focuses on the development and commercialization of drugs and other health products based on dendrimer technology. One of the most advanced applications of dendrimer technology is VivaGel, a topical gel for the prevention of sexually transmitted diseases, particularly HPV (Human Papillomavirus). VivaGel is based on a dendrimer that acts both as an antiviral agent and an antibiotic, capable of preventing infection by different types of HPV. The product has already undergone Phase III clinical trials and is currently being marketed worldwide. In addition to VivaGel, Starpharma also offers dendrimer-based technologies and services in the field of drug development. The company has formed numerous partnerships with major pharmaceutical companies such as AstraZeneca, GSK, and Merck, and is involved in the development of drugs for cancer, autoimmune diseases, and infectious diseases. Furthermore, Starpharma has expanded its dendrimer technology to other industries, such as agriculture, where dendrimers can contribute to improving soil quality and reducing pesticide use. In this sector, Starpharma has also formed partnerships with agricultural companies such as Adama and Nufarm. Overall, Starpharma is a company that has experienced significant growth in recent years and continues to focus on the development of new and innovative products and solutions. Its core competence in dendrimer technology has allowed it to establish itself as a key player in various industries and build numerous partnerships with global companies. With its diverse range of products and services and a strong focus on research and development, Starpharma can be considered an important player in the field of biotechnology and healthcare innovations. Indicate the sector in starpharma specialize in. Starpharma Holdings is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Starpharma Holdings Stock

How much dividend does Starpharma Holdings pay?

Over the past 12 months, Starpharma Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Starpharma Holdings is expected to pay a dividend of 0 AUD.

What is the dividend yield of Starpharma Holdings?

The current dividend yield of Starpharma Holdings is .

When does Starpharma Holdings pay dividends?

Starpharma Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Starpharma Holdings?

Starpharma Holdings paid dividends every year for the past 0 years.

What is the dividend of Starpharma Holdings?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Starpharma Holdings located?

Starpharma Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Starpharma Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Starpharma Holdings from 6/29/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 6/29/2024.

When did Starpharma Holdings pay the last dividend?

The last dividend was paid out on 6/29/2024.

What was the dividend of Starpharma Holdings in the year 2023?

In the year 2023, Starpharma Holdings distributed 0 AUD as dividends.

In which currency does Starpharma Holdings pay out the dividend?

The dividends of Starpharma Holdings are distributed in AUD.

Andere Kennzahlen von Starpharma Holdings

Our stock analysis for Starpharma Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Starpharma Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.